Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01945359 · ClinicalTrials.gov registry record
Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design
A clinical trial, sponsored by Rocky Mountain MS Research Group.
- Completed
- Registry status
- 30
- Enrollment target
NCT01945359 is a clinical trial that has completed, run by Rocky Mountain MS Research Group. The registered enrollment target is 30 participants.
The verdict
NCT01945359 has completed, sponsored by Rocky Mountain MS Research Group.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study will observe participants with relapsing remitting multiple sclerosis who are switching therapies from natalizumab to dimethyl fumarate to determine disease stability.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01945359
The ClinicalTrials.gov registry entry for NCT01945359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rocky Mountain MS Research Group, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01945359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01945359 about?
NCT01945359 is a clinical study titled "Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design". This study will observe participants with relapsing remitting multiple sclerosis who are switching therapies from natalizumab to dimethyl fumarate to determine disease stability.
What is the current status of trial NCT01945359?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-09. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01945359?
This trial is sponsored by Rocky Mountain MS Research Group, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.